FindTrial
Sign In

Identification and evaluation of biomarkers for screening and early diagnosis of colorectal neoplasms based on metabolomics

Identification and evaluation of biomarkers for screening and early diagnosis of colorectal neoplasms based on metabolomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040878
Enrollment
Unknown
Registered
2020-12-13
Start date
2020-12-14
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Interventions

Gold Standard:Colonoscopy findings
Index test:wide-target&#32
metabolites&#32
and&#32
lipid&#32
biomarkers

Sponsors

The Seventh Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Case group: Patients with advanced colorectal adenoma and colorectal cancer diagnosed by colonoscopy combined with pathology clinical diagnosis; Control group: 1) Healthy population; 2) Patients with other tumors (except colorectal cancer); 3) Patients with colitis and gastritis, etc.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Sensitivity;Area under ROC curve;—

Secondary

MeasureTime frame
Specificity;—

Countries

China

Contacts

Public ContactPeng Jin

The Seventh Medical Center of PLA General Hospital

dr_pengjin@qq.com+86 13466671195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026